My clinical activies are at the Mt. Sinai Medical Center in Manhattan where I am Adjunct Attending on the medical staff of the Department of Pathology. My research concerns the developement of rapid tests to detect antibiotic resistant bacteria. These currently include MRSA, VRE, VISA, CRE, Ciprofloixin, and all S. aureus. In addition I developed an inenexpensive instrument to read and report all the tests. These screens are CE/IVD in Europe and FDA waived in the U.S. In particular these are the only direct specimen tests for CRE, ciprofloxicin, and ViSA. See publication list below. These screens and thei nstrument are marketed by Pilots Point LLC of Sarasota Florida (www.pilotspoint.net). I am senior partner at Pilots Point. In addition I developed a rapid test for the detection of total coliforms and Escherichi coli from drinking water, wastewter, and other water sources. This test allows the detectionof these public health threats within hours rather than days. They are also maketed by Pilots Point LLC.
I continue to serve on panels and advisory bodies as a health risk expert for the United Nations World Health Organization, US Environmental Protection Agency, Food and Drug Administration, and others. In particular I played a central role in the generation of the US EPA's new total coliform rule.
Accepts new patients? No
Patient Type: Adult; Child
Referrals: MD to MD Consult